Acquisition (code A) of 6,430 shares at $9.72 per share.
Reporting Person Gaslightwala Abizer · Officer Title CEO · Transaction Code A
Traded Sep 29, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001493152-26-045366 · filed 2026-10-01 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Akari Therapeutics Plc (AKTX)." Disclosed 2026-10-01. https://desqlong.com/cards/0001493152-26-045366-1 (retrieved 2026-10-02).